THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

Lionbridge Technologies, Inc. (LIOX)

3/27/2006 Proxy Information

In accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, during 2005, five (5) Executive Officers established written plans which provides for the automatic sale of a specified number of shares of Common Stock in accordance with the guidelines of the written plan. Mr. Cowan’s plan provides for the sale of up to 300,000 shares through January 2007, through sales of 15,000 shares each month beginning in February 2006, provided the stock price is at or above $6.95 per share and an additional 10,000 shares each such month if the stock price is at or above $7.95 per share. Mr. Lifshatz’s plan provides for the sale of up to 200,000 shares during 2006, through sales of 50,000 shares each month beginning in February 2006, provided the stock price is at or above $7.00 per share. Mr. Broekmate’s plan provides for the sale of 7,500 shares each calendar quarter if the stock price is at or above $6.00 per share. Ms. Shannon’s plan provides for the sale of up to 7,500 shares per calendar quarter, through sales of 5,000 shares if the stock price is at or above $7.00 per share but below $9.00 per share, and an additional 2,500 shares each calendar quarter if the stock price is at or above $9.00 per share. Mr. Maripuri’s plan provides for the sale of up to 15,000 shares, through sales of 5,000 shares in a calendar quarter if the stock price is at or above $7.50 per share but below $9.00 per share, an additional 5,000 shares each calendar quarter if the stock price is at or above $9.00 per share but below $11.00 per share, and an additional 5,000 shares each calendar quarter if the stock price is above $11.00 per share.

3/22/2005 Proxy Information

Lionbridge has been engaged to provide localization services for Boston Scientific for which it receives equal and customary compensation. Mr. Goodman, a director of the Company, is Senior Vice President and President, International, of Boston Scientific. During 2004, approximately $77,000 of services was provided by the Company to Boston Scientific.